Translation from concept to clinical. Curation by Harvard Medical faculty. A focus on the path to implementation. No other conference shines a light on the transition from promise to patient.
Get an up-close look at research that will create the next wave of GCT-driven healthcare innovation. The work of principal investigators across the Mass General Brigham network presents an insightful tableau of emerging inquiry to inform investment priorities.
Boston is the global epicenter of biotech innovation. Mass General Brigham represents many of the most respected pillars of the academic research community. Each year, Mass General Brigham invites leaders from around the world to join in a dialogue that will shape the future of medicine.
Opportunities to assess the speed at which new GCT technologies will become clinical realities.
Moving GCT innovation into clinical practice depends on everything from robust research practices to prudent piloting to smart partnering. The Forum program provides insight into the pace of implementation of GCT-based products in clinical settings.
Attendees learn how 100s of clinicians set the agenda for widespread implementation of new GCT-driven technology.
Implementing GCT breakthroughs requires educating practitioners on the front lines of patient care. Mass General Brigham helps set industry priorities for clinical care, education and training.
Harvard Medical School
Brigham and Women’s Hospital
Massachusetts General Hospital
Mass. Eye and Ear
Spaulding Rehabilitation Network
Harvard Medical School investigators present their work with rapid fire presentations of their high potential new technologies which will impact the future of medicine in gene and cell therapy.
Harvard faculty from BWH and MGH select technologies that will have the greatest impact on the chosen field of the event in the next 18 months.
Nearly 50 gene and cell therapy technologies profiled by Harvard Medical School inventors and clinicians who will bring technologies to patients.